A pre-S/S CHO-derived hepatitis B virus vaccine protects woodchucks from WHV productive infection

Vaccine

Volumn 23, Issue 28, 2005, Pages 3649-3656

  Argentini, Claudio ^a   Giuseppetti, Roberto ^a   D'Ugo, Emilio ^a   La Sorsa, Valentina ^a   Tritarelli, Elena ^a   Orobello, Sara ^a   Canitano, Andrea ^a   Glück, Reinhard ^b   Rapicetta, Maria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Berna Biotech AG   (Switzerland)

Author keywords

Animal model; HBV vaccine; Woodchuck hepatitis virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG EFFICACY; HEPATITIS B; HEPATITIS VIRUS; INFECTION; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS ISOLATION; WOODCHUCK;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS, WOODCHUCK; LIVER; MARMOTA; POLYMERASE CHAIN REACTION; VIREMIA;

EID: 18844424688     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.014     Document Type: Article

References (47)

1. F.J. Mahoney Update on diagnosis, management, and prevention of hepatitis B virus infection Clin Microbiol Rev 12 2 1999 351 366
2. W.J. McAleer, E.B. Buynak, R.Z. Maigetter, D.E. Wampler, W.J. Miller, and M.R. Hilleman Human hepatitis B vaccine from recombinant yeast, 1984 Biotechnology 24 1992 500 502
3. F.E. Andre Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine Vaccine 8 1990 S74 S80
4. R.T. Marinho, M.C. Moura, M. Pedro, F.J. Ramalho, and J.F. Velosa Hepatitis B vaccination in hospital personnel and medical students J Clin Gastroenterol 28 4 1999 317 322
5. D.J. Weber, W.A. Rutala, G.P. Samsa, J.E. Santimaw, and S.M. Lemon Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine JAMA 254 22 1985 3187 3189
6. F.E. Shaw Jr., H.A. Guess, J.M. Roets, F.E. Mohr, P.J. Coleman, and E.J. Mandel Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination Vaccine 7 5 1989 425 430
7. Centers for Disease Control Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B, Unites States 1990-1991 JAMA 266 1991 1338 1339
8. W.F. Carman, A.R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, and E. Tanzi Vaccine-induced escape mutant of hepatitis B virus Lancet 336 8711 1990 325 329
9. D.R. Milich, G.B. Thornton, A.R. Neurath, S.B. Kent, M.L. Michel, and P. Tiollais Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen Science 228 4704 1985 1195 1199
10. A.R. Neurath, B. Seto, and N. Strick Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective Vaccine 7 3 1989 234 236
11. Y. Itoh, E. Takai, H. Ohnuma, K. Kitajima, F. Tsuda, and A. Machida A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees Proc Natl Acad Sci USA 83 23 1986 9174 9178
12. E.A. Emini, V. Larson, J. Eichberg, P. Conard, V.M. Garsky, and D.R. Lee Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein J Med Virol 28 1 1989 7 12
13. D. Shouval, Y. Ilan, R. Adler, R. Deepen, and W.H. Gerlich Improved immunogenicity in mice of recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in HBs particles Abstract 13 1991 S71
14. I. Yap, R. Guan, and S.H. Chan Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein - a preliminary study on immunogenicity Vaccine 10 7 1992 439 442
15. K. Madalinski Immunologenicity in children of recombinant hepatitis vaccine containing Pre-S2 and Pre-S1 antigens. Persistence of antibodies Polish J Immunol 19 1994 333 340
16. R. Raz, R. Dagan, A. Gallil, G. Brill, I. Kassis, and R. Koren Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children Vaccine 14 3 1996 207 211
17. B. Yerushalmi, R. Raz, O. Blondheim, E. Shumov, R. Koren, and R. Dagan Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates Pediatr Infect Dis J 16 6 1997 587 592
18. D. Diminsky, R. Schirmbeck, J. Reimann, and Y. Barenholz Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity Vaccine 15 6-7 1997 637 647
19. M.Y. Shapira, E. Zeira, R. Adler, and D. Shouval Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine J Hepatol 34 1 2001 123 127
20. R. Raz, R. Koren, and D. Bass Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults Isr Med Assoc J 3 5 2001 328 332
21. D. Diminsky, N. Moav, M. Gorecki, and Y. Barenholz Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles Vaccine 18 1-2 1999 3 17
22. C. Argentini, V. La Sorsa, R. Bruni, E. D'Ugo, R. Giuseppetti, and M. Rapicetta Hepadnavirus evolution and molecular strategy of adaptation in a new host J Gen Virol 80 Pt3 1999 617 626
23. V. La Sorsa, C. Argentini, R. Bruni, U. Villano, R. Giuseppetti, and M. Rapicetta In vivo transmission and dynamics of deleted genomes after experimental infection of woodchuck hepatitis B virus in adult animals Virus Genes 25 2 2002 147 157
24. P.J. Cote, M. Shapiro, R.E. Engle, H. Popper, R.H. Purcell, and J.L. Gerin Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen J Virol 60 3 1986 895 901
25. M. Klinkert, L. Theilmann, E. Pfaff, and H. Shaller Pre-S antigens and antibodies early in the course of acute hepatitis B virus infection J Virol 52 1992 522 525
26. A. Alberti, D. Cavalletto, P. Pontisso, L. Chemello, G. Tagariello, and F. Belussi Antibody response to pre-S2 and hepatitis B virus induced liver damage Lancet 1 8600 1988 1421 1424
27. S. Menne, C.A. Roneker, M. Roggendorf, J.L. Gerin, P.J. Cote, and B.C. Tennant Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation J Virol 76 4 2002 1769 1780
28. J. Coullin, S. Pol, M. Mancini, F. Driss, C. Brechot, and P. Tiollas Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens J Infect Dis 180 1 1999 15 26
29. F.V. Chisari Immunobiology and pathogenesis of viral hepatitis M. Rizzetto R.H. Purcell J.L. Gerin G. Verme Viral hepatitis and liver disease 1996 Edizioni Minerva Medica Turin, Italy 405 414
30. X. Zheng, R. Schirmbeck, G. Hilken, J.A. Waters, D. Yang, and J. Reimann Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization Virology 294 2 2002 342 353
31. P. Overath, and T. Aebischer Antigen presentation by macrophages harboring intravesicular pathogens Parasitol Today 15 8 1999 325 332
32. S. Gessani, and F. Belardelli IFN-gamma expression in macrophages and its possible biological significance Cytokine Growth Factor Rev 9 2 1998 117 123
33. M.R. Hilleman Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications Vaccine 19 15-16 2001 1837 1848
34. N. Gitlin Hepatitis B: diagnosis, prevention, and treatment Clin Chem 43 8 1997 1500 1506
35. G.J. Webster, S. Reignat, M.K. Maini, S.A. Whalley, G.S. Ogg, and A. King Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms Hepatology 32 5 2000 1117 1124
36. M.C. Jung, and G.R. Pape Immunology of hepatitis B infection Lancet Infect Dis 2 1 2002 43 50
37. S. Menne, C.A. Roneker, B.E. Korba, J.L. Gerin, B.C. Tennant, and P.J. Cote Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-l-arabinofuranosyl)-uracil (l-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection J Virol 76 11 2002 5305 5314
38. M.A. Avanzini, C. Belloni, A. De Silvestri, A.M. Castellazzi, M. Marconi, and A. Moretta Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity Clin Immunol 107 2 2003 122 128
39. J. Herkel, B. Jagemann, C. Wiegard, J.F. Lazaro, S. Lueth, and S. Kanzler MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes Hepatology 37 5 2003 1079 1085
40. M.L. Michel, and D. Loirat DNA vaccines for prophylactic or therapeutic immunization against hepatitis B Intervirology 44 2-3 2001 78 87
41. B. Spellberg, and JE. Edwards Jr. Type 1/type 2 immunity in infectious diseases Clin Infect Dis 32 1 2001 76 102
42. S. Hervas-Stubbs, J.J. Lasarte, P. Sarobe, I. Vivas, L. Condreay, and J.M. Cullen T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically infected animals treated with lamivudine Hepatology 35 1 2001 105 111
43. S. Menne, C.A. Roneker, B.E. Korba, J.L. Gerin, B.C. Tennant, and P.J. Cote Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-l-arabinofuranosyl) uracil (l-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection J Virol 76 11 2002 5305 5314
44. S. Menne, C.A. Roneker, B.C. Tennant, B.E. Korba, J.L. Gerin, and P.J. Cote Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection Intervirology 45 4-6 2002 237 250
45. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, and S.I. Staprans Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 5514 2001 69 74
46. D.H. Barouch, S. Santra, J.E. Schmitz, M.J. Kuroda, T.M. Fu, and W. Wagner Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination Science 290 5491 2000 486 492
47. M.P. Davenport, R.M. Ribeiro, D.L. Chao, and A.S. Perelson Predicting the impact of a non-sterilizing vaccine against human immunodeficiency virus J Virol 78 20 2004 11340 11351